UK Artificial Intelligence (AI) in Medical Imaging market size was valued at $39 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.4% from 2022 to 2030 and will reach $391 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The UK Artificial Intelligence (AI) in the Medical Imaging market will grow because AI technologies can help improve the accuracy and efficiency of medical imaging, leading to better patient outcomes and reduced healthcare costs. Some of the key players in this market are Optellum, Kheiron Medical, Aidoc, Sophia Genetics, Ultromics, Brainomix, MaxQ AI, Faculty, Sensyne Health, Feedback Medical, Cambridge Medical Imaging, Perspectum, Oxipit, Qure.ai, Quantib, Imagen, Mirada Medical, Kromek Group, GTN, 4D Imaging, and others.
Market Executive Summary
UK Artificial Intelligence (AI) in Medical Imaging market size was valued at $39 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.4% from 2022 to 2030 and will reach $ 391. The UK government has made significant investments in healthcare technology, including AI, in recent years. In November 2020, the UK government announced a $3.56 Bn investment in the National Health Service (NHS) to support the implementation of new technology, including AI. This funding will be used to upgrade existing technology infrastructure and to develop new AI-powered tools for use in healthcare.
In addition to government investment, private sector investment in AI in healthcare is also growing in the UK. In 2019, UK healthcare AI startups raised a record-breaking $237.10 Mn in funding, indicating a growing interest in the potential of AI in healthcare. While the exact amount of healthcare spending specifically on AI technology in the UK is difficult to quantify, it is clear that the government and private sector are both investing heavily in this area. As the benefits of AI in healthcare become increasingly apparent, it is likely that this investment will continue to grow in the coming years.
Artificial Intelligence (AI) in Medical Imaging is an emerging field that is transforming the way medical images are analyzed, interpreted, and used for diagnosis and treatment. In the UK, there has been growing interest and investment in AI-powered medical imaging technologies in recent years, with several startups and established companies developing innovative solutions for various medical imaging applications. One of the primary drivers of the AI in Medical Imaging market in the UK is the increasing demand for advanced diagnostic tools, particularly in the areas of cancer and cardiovascular disease. AI technologies can help improve the accuracy and efficiency of medical imaging, leading to better patient outcomes and reduced healthcare costs.
The use of Artificial Intelligence (AI) in Medical Imaging is not limited to any specific region in the UK, and it is being implemented and researched in various regions across the country. Here are some examples of regions in the UK where AI in Medical Imaging is being used for example, London is a hub for AI research and development, and several startups and established companies in the city are developing AI-powered medical imaging solutions. The London Medical Imaging and AI Centre for Value-Based Healthcare is a research center that is focused on developing AI tools for cancer diagnosis and treatment.
The University of Manchester has a dedicated research center for medical imaging, and researchers there are using AI to improve the accuracy of breast cancer screening. Additionally, The University of Oxford has developed an AI-powered imaging technology called HeartFlow, which uses AI to create 3D models of the heart and can help diagnose and treat coronary artery disease.
The University of Edinburgh has a research center focused on AI and medical imaging, and researchers there are developing AI algorithms to improve the diagnosis of prostate cancer. Furthermore, Cambridge is home to several AI startups and established companies that are developing medical imaging solutions. For example, Cambridge-based startup Optellum is using AI to improve the diagnosis of lung cancer. These are just a few examples of regions in the UK where AI in Medical Imaging is being used. The implementation of AI in medical imaging is a growing trend across the UK, and it is expected to continue to expand in the coming years.
Market Growth Drivers
The UK Artificial Intelligence (AI) in Medical Imaging market is driven by several factors, including increasing demand for advanced diagnostic tools, growing investment in AI research and development, and a supportive regulatory framework. AI technologies can help improve the accuracy and efficiency of medical imaging, leading to better patient outcomes and reduced healthcare costs. The increasing prevalence of chronic diseases such as cancer and cardiovascular disease is also driving demand for AI-powered imaging solutions.
the market faces several restraints, including data privacy concerns, limited availability of annotated medical images, and the high cost of AI technology. The integration of AI into existing healthcare systems can also pose challenges, including workforce retraining, data management, and regulatory compliance. Additionally, the COVID-19 pandemic has created disruptions in healthcare systems and reduced funding for research and development, which may impact the growth of the AI in Medical Imaging market. Despite these challenges, the market is expected to continue to grow as AI technology advances and its benefits become more widely recognized in the healthcare industry.
March 2021: Kheiron Medical, a UK-based AI medical imaging startup, announced it had raised $22 Mn in funding to expand its breast cancer screening AI technology.
February 2021: The University of Oxford announced that its AI-powered imaging technology had been approved for use in the NHS. The technology, called HeartFlow, uses AI to create 3D models of the heart and can help diagnose and treat coronary artery disease.
Policy changes and Reimbursement scenario
The UK has several regulations and guidelines in place regarding the use of Artificial Intelligence (AI) in Medical Imaging. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medical devices, including those that incorporate AI. Manufacturers must comply with safety and effectiveness requirements and obtain the necessary approvals before bringing their products to market.
The General Data Protection Regulation (GDPR) outlines requirements for the processing of personal data, including medical images, in the EU. This regulation applies to AI applications in medical imaging that process personal data.
The National Institute for Health and Care Excellence (NICE) provides guidelines on the use of AI in healthcare. These guidelines aim to promote safe and effective use of AI in healthcare while highlighting areas that require further research and development.
The Royal College of Radiologists (RCR) has developed guidelines for the use of AI in radiology. These guidelines provide recommendations on the ethical, legal, and technical aspects of AI use in radiology.
The NHS AI Lab was established to support the safe and effective implementation of AI in healthcare. The lab provides a platform for collaboration between the NHS, industry, and academia to drive innovation and improve patient outcomes.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
188.8.131.52 Product Applications and Services
184.108.40.206 Recent Developments
220.127.116.11 Partnerships Ecosystem
18.104.22.168 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By AI Technology
When compared to CT scans, magnetic resonance imaging can produce pictures that are free of imperfections. Due to its efficiency in obtaining details and better-quality pictures of soft tissues, the MRI is frequently seen as a superior alternative to X-rays. Utilizing optical coherence tomography, three-dimensional interactions between the retina and membranes are made possible in order to control the vitreoretinal disease.
The market is dominated by the digital pathology segment, which can be linked to pathologists' rising productivity. A validation tool for image analytics is provided by digital pathology, helping pathologists process more slides in less time. This facilitates early illness identification and quicker therapy initiation. AI and digital pathology also assist doctors in making patient-centered decisions. The oncology market is also expected to grow in popularity as more individuals become aware of cancer and its increased incidence in the public. Personalized therapy is made possible by artificial intelligence algorithms that identify and comprehend the nature of malignancies. The second section focUses on AI-driven diagnostic imaging for the heart, brain, breast, and mouth.
By End Use
The market is dominated by the healthcare sector. This is becaUse hospitals are widely dispersed and accessible; hence, many patients like hospitals. The market for medical imaging AI is also anticipated to benefit from favorable reimbursement regulations. During the anticipated time, diagnostic centers are anticipated to grow in popularity. This may be attributable to elements including rising patient awareness and a desire for diagnostic procedures and tests, all of which are fueling the market's expansion. Due to its ease in providing high-quality medical facilities in remote places, particularly rural ones, the ambulatory category is expected to develop at a quicker CAGR throughout the projection period. The availability of qualified surgeons and a surplUK of the necessary equipment are contributing to the expansion of the hospital market. Government assistance in emerging nations is likely to boost hospital infrastructure and technologies throughout the forecast period, which is anticipated to caUse the hospital segment to see growth.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses